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Comparison of Endometrial Thickness 
with Concomitant Administration of 
Sildenafil Citrate and Ethinyl Estradiol 
vs Ethinyl Estradiol Alone for Frozen 
Embryo Transfer
INTRODUCTION
One of the most common healthcare problems that affect couples 
across the world, including Iran, is infertility [1-3]. It also imposes 
a high burden on families and the health system in developing 
countries [4]. To achieve successful implantation in Assisted 
Reproductive Technology (ART), ET should be taken into account 
to increase the likelihood of fertility [5,6].
Several therapies are available to bring the ET to the best 
possible thickness during the implantation window. For example, 
estrogen, by increasing blood supply to the endometrium, 
induces endometrial tissue proliferation and increases ET [7,8]. 
Sildenafil citrate also increases the uterine blood flow and, 
by binding to estrogen, leads to an increase in the efficacy of 
estrogen-induced proliferation in the endometrium lining [9]. 
Also, E2 is one of the popular therapies for ET [8]. However, 
despite the fact that there are several treatments for increasing 
ET, the efficacy of these treatments remains to be definitely 
established [8]. Therefore, the present study was done with the 
aim to compare the effect of E2 alone on ET with that of sildenafil 
citrate and E2 combination for Frozen Embryo Transfer (FET) in 
infertile women undergoing ARTs.
MATERIALS AND METHODS
This prospective clinical trial was conducted on 70 infertile women 
undergoing ARTs {In Vitro Fertilisation (IVF) and intracytoplasmic 
sperm injection} referred to the Infertility Clinic of Hamadan Fatemiyeh 
Hospital (Hamadan Endometriosis Centre). This study was begun in 
February 2016 and was ended in March 2017.
The protocol of the present study was registered as the 
IRCT201704119014N156 at the Iranian Registry of Clinical Trials. 
According to a study conducted in this field [10], the sample size 
was determined as 28 for each group according to a formula for 
comparing two ratios that were evaluated on the basis of the 
same ET, and to account for the dropout of 20% of the samples, 
the result was multiplied by 1.25, and therefore final sample 
size in each group was calculated as 35 people. Samples were 
entered into the study by census. The sampling was performed 
by randomised block consisting of 10 columns and 7 rows in 
which the treatment groups were randomly assigned the letters A 
and B, that were randomly allocated to the treatment groups by 
the prescribing person.
Inclusion criteria included age under 40 years, idiopathic infertility, 
ovulation problems that did not respond to several periods of 
ovulation induction and Intrauterine Insemination (IUI), fallopian tube 
and endometriosis problems, lack of using a Nitric Oxide (NO)-
lowering drug, the presence of at least one embryo with grade 
A or B, and the lack of concomitant use of other ARTs. After the 
detection of the cause of infertility following examinations and 
analysis of the tests including hormone analysis, sperm analysis, 
and hysterosalpingography, the type of treatment for patients was 
selected and patients who had the indication for the use of ARTs 
were included in the study. The presence of hydrosalpinx in one or 
two fallopian tubes, having embryos with grade C or lower, and lack 
of providing consent to participate in the study were determined as 
the exclusion criteria.
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ABSTRACT
Introduction: Infertility is one of the common medical issues 
in today’s world. One of the common causes of infertility is the 
lack of implantation of the embryo.
Aim: To compare the effect of Ethinyl Estradiol (E2) alone on 
Endometrial Thickness (ET) with that of sildenafil citrate and E2 
combination.
Materials and Methods: In this clinical trial, 70 infertile women 
undergoing treatment with Assisted Reproductive Techniques 
(ARTs) were randomly divided into two groups of 35 each. 
One group received E2 and vaginal sildenafil and the other 
E2 alone. On the seventh day of the cycle and, if necessary, 
until ET reached 8 mm, ET in both groups was measured by 
transvaginal ultrasound. After the embryo transfer, Beta-Human 
Chorionic Gonadotropin (BHCG) was performed in both groups. 
The measured thickness of uterus and BHCG were recorded in 
the checklist for both groups. Data were analysed by SPSS and 
p<0.05 was considered significant.
Results: The mean duration (in days) to reach an 8 mm ET in 
infertile women in the E2+sildenafil group (13.59±3.07) was 
lower than that in the E2 group (14.88±4.78), yet insignificant 
(p=0.21). Although the mean dose (mg) of E2 and duration (day) 
to reach an 8 mm ET in the E2+sildenafil group was lower than 
those in the E2 group, significance (p) levels were 0.02 and 
0.21, respectively.
Conclusion: In infertile women undergoing ARTs, co-
administration of sildenafil citrate and E2 increased ET 
relatively and reduced the dose of E2 and the duration of its 
administration.
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The 70 patients who were included in the study were divided into 
two groups of 35 each; the patients in the group 1 received 25 mg 
vaginal sildenafil four times a day+6 mg E2 from the second or 
third day of the cycle, and the group 2 received only 6 mg E2; and 
on the seventh day, transvaginal ultrasound was performed, and 
according to the status of endometrium, we investigated whether 
ET had reached 8 mm or higher, and also the dosage of drugs was 
gradually increased until ET reached 8 mm or higher. The researcher 
who measured the ET was blind to the grouping of the patients.
Ovulation stimulation was performed by one of the appropriate 
protocols for the patient. After the egg was collected, IVF or 
microinjection was performed on oocytes and the fertilised embryos 
were transferred to the uterus at the appropriate time [11].
It should be noted that in order to eliminate the risk of excessive 
ovarian hyperstimulation syndrome, none of the patients whose 
number of follicles was more than 11 were included in the study. 
The causes of frozen embryo in our study included cervical stenosis, 
inappropriate endometrium, high number of foetuses, and systemic 
disorders [12]. The result of the treatment cycle was followed-up 
by performing Beta-Human Chorionic Gonadotropin (BHCG) on 
day 14 after embryo transfer. The data were then recorded in the 
checklist of the outcomes of the intervention.
STATISTICAL ANALYSIS
After data collection, the SPSS version 16 was used to analyse the 
data. To describe the quantitative data, mean (±Standard Deviation) 
and quadrant were used and to describe qualitative data, frequency 
was used. To compare average ET between the two groups, 
parametric t-test was used.
RESULTS
In this study, 70 infertile women undergoing ARTs were assigned to 
two groups of 35 each, underwent treatment with E2 and sildenafil 
citrate, and then studied.
There was no statistically significant difference in the number of 
transferred embryos, number of previous pregnancies, number of 
abortions, number of cycles, number of retrieved eggs, and number 
of fertilised eggs between the E2 group and the E2+sildenafil citrate 
group (p>0.05).
There was also no significant difference in intervention type and ART 
between the average ET on the seventh day of the cycle (p=0.85). 
There was no significant difference in the duration to reach an ET of 
8 mm between the two groups (p=0.83) [Table/Fig-1].
For the cause of infertility in the group treated with E2, the most 
common cause was male factor {n: 18 (51.4%)} followed by uterus 
{n: 7 (20%)} and idiopathic {n: 10 (28.6%)}; and in the group treated 
with E2+sildenafil citrate, the most common cause was male factor 
{n: 21 (60%)} followed by uterus {n: 5 (14.3%)} and idiopathic 
{n: 9 (25.7%)}. The mean ET score on the seventh day was not 
significantly different between the E2+sildenafil citrate group and the 
E2 group (p=0.367) [Table/Fig-3].
treatment group
Days
7-10 11-13 14-17 18≤ total
n (%) n (%) n (%) n (%) n (%)
E2 3 (8.6) 15 (42.8) 8 (22.9) 9 (25.7) 35 (100)
E2+Sildenafil citrate 2 (5.7) 13 (37.1) 10 (28.6) 10 (28.6) 35 (100)
Total 5 (7.1) 28 (40) 18 (25.7) 19 (27.1) 70 (100)
[Table/Fig-1]: Comparison of the duration to reach an endometrial thickness of 
8 mm based on treatment.
Fisher’s-exact test: χ2=0.62, p=0.083
treatment group age group number Mean±SD p-value
E2 <30 12 6.72±1.15
0.36≤30 23 5.95±1.61
Total 35 6.23±1.49
E2+Sildenafil citrate
<30 11 6.57±0.95
0.96≤30 24 6.32±1.12
Total 35 6.64±1.07
[Table/Fig-2]: Comparison of mean endometrial thickness score on the seventh 
day between the ethinyl estradiol group and the sildenafil citrate+ethinyl estradiol 
group by age.
treatment group infertility causes Mean±SD
E2
Male 6.45±1.41
Ovarian 6.50±1.06
Unknown 5.97±0.51
Total 6.32±1.12
E2+Sildenafil citrate
Male 6.21±1.01
Ovarian 6.47±1.66
Unknown 1.29±2.49
Total 5.93±1.61
Total
Male 6.32±1.21
Ovarian 6.49±1.24
Unknown 5.53±1.64
Total 6.15±1.36
[Table/Fig-3]: Comparison of mean endometrial thickness score on the seventh 
day between the ethinyl estradiol group and the sildenafil citrate+ethinyl estradiol 
group by the cause of infertility.
Embryo grade
treatment group
p-value
E2 E2+Sildenafil citrate
Morella 16 13 0.94
Blast 8 3 0.34
4Cell A 2 0 0.25
4Cell B 1 0 0.75
6Cell A 0 2 0.25
6Cell B 0 0 <0.001
8Cell A 13 9 0.22
8Cell B 7 4 0.36
16Cell A 2 6 0.13
16Cell B 0 2 0.25
18Cell A 0 0 <0.001
18Cell B 0 13 0.94
[Table/Fig-4]: Comparison of embryo grade between treatment groups.
The mean duration (day) to reach an 8 mm ET in infertile women 
in the E2+sildenafil group (13.59±3.07) was lower than that in 
the E2 group (14.88±4.78), yet insignificant (p=0.21). The mean 
dose (mg) of E2 needed to reach an 8 mm ET in the E2+ sildenafil 
group (108.59±85.42) was lower than that (131.71±49.69) in the 
E2 group (p=0.2).
There was no significant difference between mean age of infertile 
women treated with E2 (31.54±5.41) and those treated with E2+ 
sildenafil citrate (31.34±5.26) (p=0.876) and the two groups were 
matched by age. There was no significant difference in the mean 
ET score between infertile women treated with E2 alone and those 
treated with E2+ sildenafil citrate (p>0.05) [Table/Fig-2].
There was no significant difference in the duration of infertility (year) 
between infertile women treated with E2 (7.83±4.18) and those 
treated with E2+sildenafil citrate (4.12±5.80) (p=0.117). There was 
also no significant difference in embryo grade between infertile 
women treated with E2 and those treated with E2+sildenafil citrate 
(p>0.05) [Table/Fig-4].
The number of BHCG positive cases in the sildenafil citrate+E2 
group was 9 (25.7%) and in the E2 group 11 (31.4%) (χ2=0.28, 
p=0.396) [Table/Fig-5].
www.jcdr.net Mahnaz Yavangi et al., Effect of Ethinyl Estradiol Alone and Combined with Sildenafil Citrate on Endometrial Thickness
Journal of Clinical and Diagnostic Research. 2019 Jan, Vol-13(1): QC05-QC08 7
DISCUSSION
In the present study there are no effect on embryo grade and positive 
BHCG was observed after concomitant use of E2 and sildenafil 
citrate. In a study that evaluated the effect of sildenafil citrate on 
ET in the control and sildenafil groups, the results showed that the 
drug could significantly increase ET and triple-line patterns in the 
endometrium.
However, intermediate patterns did not differ between the two 
groups [13]. In another study by Malinova M et al., the results 
indicated that vaginal consumption of sildenafil citrate and 
serophene in infertile women, by increasing uterine blood flow, 
increased endometrial thickness and can be used as an effective 
treatment method for ovulation induction [14]. In another study, it 
was found that vaginal administration of sildenafil, in addition to a 
70% increase in ET in the studied women, also caused pregnancy 
in infertile women to persist [15].
The study of Soliman et al., showed that thermosensitive sildenafil 
vaginal gel significantly improved ET and uterine blood flow (without 
any side effects). Sildenafil vaginal ointment also reduced the dose 
and duration of treatment [16]. Sildenafil also had positive outcomes 
with respect to increase in ET in two women with Asherman’s 
syndrome [17]. In infertile women with lower ET, treatment with 
vitamin E, l-arginine, or sildenafil citrate could increase ET [18]. 
Sildenafil can increase the ET by inducing the vasodilator property 
[19]. Recently, NO synthase isoforms have been identified in the 
uterus and the role of NO as a uterine blood flow modulator has been 
identified [17]. It has been shown that NO plays a role in relaxing 
vascular smooth muscle through the cyclic Guanyl Monophosphate 
(cGMP) mediated pathway.
This drug inhibits cGMP specific phosphodiesterase type 5 (PDE5) 
by inhibiting cGMP degradation, thereby enhancing the effect of 
NO and ultimately increasing blood flow and ET [13,15]. On the 
other hand, implantation success depends on the ability of the 
blastocyst to penetrate the endometrium and to create a source 
of blood that requires certain genes such as Plasminogen Activator 
Inhibitor 1 (PAI-1), tumour suppressor factor (p53), and Vascular 
Endothelial Growth Factor (VEGF) for the production of proteins that 
are required for digestion of the endometrial cell matrix, regulation 
of cell growth, and induction of angiogenesis; sildenafil can enhance 
the angiogenesis by increasing the expression of p53 and VEGF 
[20-22].
In a study, it was shown that Clomiphene Citrate (CC) could 
have adverse effects, including decreased ET and uterine volume 
growth at the follicular phase. E2 neutralised these malignant 
effects and increased uterine development at the follicular phase 
[23]. Other study also found that adding vaginal E2 to CC during 
the stimulation period could increase ET on ovulation day and 
the following day. However, this increase in ET did not lead to an 
increase in fertility [24,25].
For the foetus to be able to attach to the endometrial wall, specific 
molecular and cellular changes in the endometrium, especially the 
luminal epithelium and its glands, should be induced. The induction 
is mediated by steroid hormones (oestrogen and progesterone). 
Any disorder in these hormones can disrupt uterine acceptance and 
ultimately result in unsuccessful implantation of the foetus [26,27].
LIMITATION
Lack of examination of the effects of the drugs that were used in the 
study on ovulation was the limitation of the present study.
CONCLUSION
In infertile women undergoing ARTs, co-administration of sildenafil 
citrate and E2 increased ET relatively and reduced the dose of E2 and 
the duration of its administration. However, after co-administration, 
no effect on the embryo grade and the number of positive BHCG 
cases were observed.
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